We will respond to all requests related to CMC from the early stages of development to the application!
We will introduce our representative formulation technology along with specific examples. The "oral disintegrating tablet" is designed to rapidly disintegrate and dissolve upon contact with saliva. It has received high praise from clinical settings not only for its efficacy but also for its formulation characteristics. On the Spira Pharma website, we have published a schematic diagram of the cross-section of enteric-coated granules, which you can view through the related link below. 【Case Summary】 ■ Designed to rapidly disintegrate and dissolve upon contact with saliva ■ Development and commercialization of oral disintegrating tablets containing enteric-coated granules ■ Highly praised in clinical settings for both efficacy and formulation characteristics *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.